These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 8727806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS.
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Managing superficial bladder cancer: an overview.
    Soloway MS.
    Urology; 1992 Dec; 40(6 Suppl):5-10. PubMed ID: 1466119
    [Abstract] [Full Text] [Related]

  • 9. Intravesical therapy for bladder cancer.
    Soloway MS.
    Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
    [Abstract] [Full Text] [Related]

  • 10. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
    Martínez-Piñeiro JA, Jiménez León J, Martínez-Piñeiro L, Fiter L, Mosteiro JA, Navarro J, García Matres MJ, Cárcamo P.
    J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
    [Abstract] [Full Text] [Related]

  • 11. Bacillus Calmette-Guérin immunotherapy. Techniques and results.
    Brosman SA.
    Urol Clin North Am; 1992 Aug; 19(3):557-64. PubMed ID: 1636239
    [Abstract] [Full Text] [Related]

  • 12. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
    Pham HT, Soloway MS.
    Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
    [Abstract] [Full Text] [Related]

  • 13. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS.
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract] [Full Text] [Related]

  • 14. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.
    Böhle A, Bock PR.
    Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879
    [Abstract] [Full Text] [Related]

  • 15. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
    Steinbach F, Schuster F.
    Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
    [Abstract] [Full Text] [Related]

  • 16. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [Abstract] [Full Text] [Related]

  • 17. Intravesical chemotherapy.
    Prout GR.
    Prog Clin Biol Res; 1984 Jan; 162B():125-50. PubMed ID: 6438639
    [No Abstract] [Full Text] [Related]

  • 18. Intravesical therapy for superficial bladder cancer.
    Malkowicz SB.
    Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
    [Abstract] [Full Text] [Related]

  • 19. [Superficial bladder cancer: prophylaxis of recurrence and progression].
    Miyanaga N, Akaza H, Koiso K.
    Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939
    [Abstract] [Full Text] [Related]

  • 20. Treatment of superficial carcinoma of the bladder.
    Paulson DF.
    Prog Clin Biol Res; 1984 Nov; 162B():193-209. PubMed ID: 6209720
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.